Loading
Unnatural Products
Unnatural Product's AI-enhanced drug discovery and development technology engineers entirely new drugs from passively permeable, macrocyclic peptides that can reach traditionally undruggable targets.
Funding
Every round, secondary, debt facility or acquisition involving Unnatural Products that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—